Keywords: essence, study, finds, lovenox, beats, heparin, results
ESSENCE Study Finds Lovenox Beats Heparin
Article | 25 November 1996
Results of an international clinical trial involving over 3,000 patients have revealed that Rhone-Poulenc Rorer's low-molecular weight heparin product Lovenox/Clexane ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
